Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
Traditional tax-qualified long-term care insurance policies now have new tax deductibility limits, according to the IRS.
U.S. health officials said Monday they plan to overhaul the nation’s decades-old system for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and related products.
A draft Trump administration rule that would penalize immigrants seeking green cards for accessing social services — including Medicaid — could cause thousands of kids to lose their health insurance, some advocates fear.
HealthCare.gov signup activity continued to improve during the third week of the open enrollment period for individual major medical coverage that starts Jan. 1, 2019. Managers of the Affordable Care Act public exchange enrollment and administration system report that 748,244 households selected plans during the third week of the 2019 open enrollment period, which ended Nov. 17.
Fewer people are signing up for ObamaCare plans this year compared to a similar period last year, according to data released Wednesday by the Trump administration.
Democrats will scrutinize the Trump administration’s decision not to defend Obamacare in federal court, when Democrats take control of the U.S. House of Representatives next year, a leading Democrat said on Monday.
Insurance Commissioner Dave Jones today issued a notice to insurers requesting they agree to expediting claims handling for Camp and Woolsey wildfire survivors in order to help them begin the recovery and rebuilding process more quickly.
Rep. Frank Pallone Jr. (D-N.J.), who is slated to be the next chairman of a House committee overseeing drug prices, said Wednesday that his top priorities on the issue are allowing Medicare to negotiate prices and speeding the approval of cheaper generic drugs.
Express Scripts Holding Co. and other pharmacy-benefit managers make money by negotiating drug prices on behalf of health-plan providers. The list prices that pharmaceutical companies set for their drugs diverge wildly from their real cost, and PBMs widen and feast on the gap, which helps make them some of the principal beneficiaries of America’s byzantine pricing system.
Supporters of the nation’s health law condemn them. A few states, including California and New York, have banned them. Other states limit them.